Peer-influenced content. Sources you trust. No registration required. This is HCN.

Features:
CME JOBS OUTBREAKS PEER-TO-PEER QUIZZES & QUESTIONS MEDTECH

British Medical JournalComparative Effectiveness of BNT162b2 vs. mRNA-1273 COVID-19 Vaccine Boosting in England: Matched Cohort Study in OpenSAFELY-TPP

In a study population of nearly 3.25 million adults receiving COVID boosters from November 2021 through February 2022, the 20-week risk per 1,000 for contracting COVID was 164.2 for the Pfizer-BioNTech vaccine and 159.9 for the Moderna vaccine.

Was this Essential useful?

More Essentials From

ACP Internist
Annals of Internal Medicine
British Medical Journal
Cancer Therapy Advisor
Cleveland Clinic Journal of Medicine
Clinical Advisor
Consultant360
Dana-Farber Cancer Institute
Healthgrades for Professionals
MDLinx
Neurology Advisor
OBR Oncology
Oncology Learning Network
Psych Congress Network
Psychiatrist.com
The Epoch Times
The New England Journal of Medicine
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form